TIAA-CREF Funds has released its latest investment portfolio update, detailing significant financial metrics as of August 31, 2026. The filing, submitted on October 29, 2026, is a crucial indicator of the company's financial health and investment strategy.
The update reveals that TIAA-CREF Funds holds total assets of approximately $225.96 million, with total liabilities reported at $85,045. This results in net assets of about $225.88 million, indicating a stable financial position for the firm.
Background
TIAA-CREF Funds, identified by CIK 0001084380, operates under the investment category. The company is incorporated in Delaware and has a fiscal year ending on September 30. The firm has undergone name changes in the past, previously known as TIAA CREF Institutional Mutual Funds until April 15, 1999. Recent filings include multiple NPORT-P forms submitted on the same date, October 29, 2026, showcasing the company's ongoing reporting activities.
What the Filing Says
The filing states, "The total assets amount to $225,960,528.00 and total liabilities are $85,045.00, resulting in net assets of $225,875,483.00." This detailed financial snapshot provides insights into the company's current standing and investment management strategy.
Impact
This update may affect current and potential investors, as well as stakeholders who rely on transparent reporting for decision-making. The investment management industry, particularly firms competing in asset management, will also take note of TIAA-CREF's performance metrics as they assess their own strategies and market positioning.
What's Next
The filing does not say what happens next, leaving stakeholders to anticipate future updates and potential changes in investment strategy.
Source: SEC Accession Number 0001084380-26-001345
Read Next
Kinney Virginia reports stock transaction in NRG Energy
Fitzgerald Scott Michael reports share transaction at StubHub
Baker Eric Howard Acquires 18,130 Shares of StubHub Holdings
Hart Scott Barton Acquires Shares in NRG Energy, Inc.
Arcutis Biotherapeutics reports stock ownership update
Jazz Pharmaceuticals Director Sells 6,000 Shares in Transaction





